These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1549722)

  • 1. [Synthesis of vaccine].
    Nerome K
    Tanpakushitsu Kakusan Koso; 1992 Feb; 37(3 Suppl):440-64. PubMed ID: 1549722
    [No Abstract]   [Full Text] [Related]  

  • 2. Rabies vaccine: traditional and novel approaches.
    Kieny MP; Desmettre P; Soulebot JP; Lathe R
    Prog Vet Microbiol Immunol; 1987; 3():73-111. PubMed ID: 3078836
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation, identification and certain characteristics of a Hantaan virus proposed as candidate virus for killed vaccine.
    Xie Y; Hang C; Wang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):27-30. PubMed ID: 11503020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
    Whelan SP; Evans D; Almond JW
    Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
    [No Abstract]   [Full Text] [Related]  

  • 5. A recombinant subunit vaccine approach to HCMV vaccine development.
    Spaete RR
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):90-6. PubMed ID: 1648843
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic glycopeptides for the development of cancer vaccines.
    Liakatos A; Kunz H
    Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold-adapted influenza viruses for use as live vaccines for man.
    Maassab HF; Heilman CA; Herlocher ML
    Adv Biotechnol Processes; 1990; 14():203-42. PubMed ID: 2222834
    [No Abstract]   [Full Text] [Related]  

  • 8. The MAP system. A flexible and unambiguous vaccine design of branched peptides.
    Nardelli B; Tam JP
    Pharm Biotechnol; 1995; 6():803-19. PubMed ID: 7551249
    [No Abstract]   [Full Text] [Related]  

  • 9. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Microbiol Sci; 1985 May; 2(5):129-30, 133-8. PubMed ID: 2978963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunization against HIV. Problems in developing a vaccine].
    Uhl D
    Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry.
    Zeng W; Jackson DC; Rose K
    J Pept Sci; 1996; 2(1):66-72. PubMed ID: 9225247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.
    Hanke T; McMichael AJ
    Nat Med; 2000 Sep; 6(9):951-5. PubMed ID: 10973301
    [No Abstract]   [Full Text] [Related]  

  • 13. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular dynamics of the alpha-helical epitope of a novel synthetic lipopeptide foot-and-mouth disease virus vaccine.
    Krug M; Folkers G; Haas B; Hess G; Wiesmüller KH; Freund S; Jung G
    Biopolymers; 1989 Jan; 28(1):499-512. PubMed ID: 2470437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine production in Neurospora crassa.
    Allgaier S; Taylor RD; Brudnaya Y; Jacobson DJ; Cambareri E; Stuart WD
    Biologicals; 2009 Jun; 37(3):128-32. PubMed ID: 19285427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic vaccines. Peptides of fortune.
    Janeway C
    Nature; 1991 Oct; 353(6347):792. PubMed ID: 1944552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Construction of original artificial immunogens--candidate vaccines against HIV-1].
    Lebedev LR; Gileva IP; Karpenko LI; Eroshkin AM
    Mol Gen Mikrobiol Virusol; 2000; (3):36-40. PubMed ID: 10975080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the new acellular recombinant pertussis vaccine.
    Rappuoli R; Pizza M; Podda A; De Magistris MT; Ceccarini C; Nencioni L
    Arch Inst Pasteur Tunis; 1994; 71(3-4):557-63. PubMed ID: 8801858
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetically engineered herpesvirus vaccines. Accomplishments in pigs and prospects in humans.
    Kit S; Kit M
    Prog Med Virol; 1991; 38():128-66. PubMed ID: 1647043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.